Kelly Shi
Stock Analyst at Jefferies
Total Price Targets
13
Stocks Covered
12
Sectors
Healthcare
Most Recent
Feb 26, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Kelly Shi
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| VRDN | Viridian Therapeutics, Inc. | $45.00 | $13.41 | +235.6% | 1 | Feb 26, 2026 |
| GLUE | Monte Rosa Therapeutics, Inc. | $22.00 | $18.98 | +15.9% | 1 | Dec 17, 2025 |
| PTCT | PTC Therapeutics, Inc. | $77.00 | $65.06 | +18.4% | 2 | Oct 28, 2025 |
| KYMR | Kymera Therapeutics, Inc. | $64.00 | $81.54 | -21.5% | 1 | Jun 25, 2025 |
| SMMT | Summit Therapeutics Inc. | $44.00 | $16.11 | +173.1% | 1 | Apr 25, 2025 |
| KROS | Keros Therapeutics, Inc. | $107.00 | $11.48 | +832.1% | 1 | Nov 5, 2024 |
| INCY | Incyte Corporation | $84.00 | $96.41 | -12.9% | 1 | Oct 29, 2024 |
| SNDX | Syndax Pharmaceuticals, Inc. | $37.00 | $19.18 | +93.0% | 1 | Jun 28, 2024 |
| PROK | ProKidney Corp. | $6.00 | $1.94 | +210.1% | 1 | Jun 10, 2024 |
| COGT | Cogent Biosciences, Inc. | $20.00 | $36.84 | -45.7% | 1 | Mar 30, 2024 |
| ADCT | ADC Therapeutics S.A. | $13.00 | $3.82 | +240.3% | 1 | Mar 13, 2024 |
| IBRX | ImmunityBio, Inc. | $8.00 | $7.11 | +12.6% | 1 | Aug 3, 2022 |
Recent Activity
- Feb 26, 2026— Set$45.00price target onVRDN(Viridian Therapeutics, Inc.)
- Dec 17, 2025— Set$22.00price target onGLUE(Monte Rosa Therapeutics, Inc.)
- Oct 28, 2025— Set$77.00price target onPTCT(PTC Therapeutics, Inc.)
- Jun 25, 2025— Set$64.00price target onKYMR(Kymera Therapeutics, Inc.)
- Apr 25, 2025— Set$44.00price target onSMMT(Summit Therapeutics Inc.)
- Nov 5, 2024— Set$107.00price target onKROS(Keros Therapeutics, Inc.)
- Oct 29, 2024— Set$84.00price target onINCY(Incyte Corporation)
- Jun 28, 2024— Set$37.00price target onSNDX(Syndax Pharmaceuticals, Inc.)
- Jun 10, 2024— Set$6.00price target onPROK(ProKidney Corp.)
- May 20, 2024— Set$46.00price target onPTCT(PTC Therapeutics, Inc.)
- Mar 30, 2024— Set$20.00price target onCOGT(Cogent Biosciences, Inc.)
- Mar 13, 2024— Set$13.00price target onADCT(ADC Therapeutics S.A.)
- Aug 3, 2022— Set$8.00price target onIBRX(ImmunityBio, Inc.)
Frequently Asked Questions
Who is Kelly Shi?
Kelly Shi is a stock analyst at Jefferies covering 12 stocks primarily in Healthcare. They have issued 13 price targets since Aug 3, 2022.
What stocks does Kelly Shi cover?
Kelly Shi currently covers 12 stocks, including PTCT, VRDN, GLUE, KYMR, SMMT.
What is Kelly Shi's latest price target?
Kelly Shi's most recent price target was $45.00 on VRDN (Viridian Therapeutics, Inc.), set on Feb 26, 2026.
What is Kelly Shi's highest price target?
Kelly Shi's highest issued price target is $107.00 on KROS, set on Nov 5, 2024.
More Analysts at Jefferies
Coverage based on publicly published price targets. Not investment advice.